• Version
  • Download 2
  • File Size 0.00 KB
  • File Count 1
  • Create Date May 16, 2024
  • Last Updated May 16, 2024

ASCO in an Hour

From BTOG Webinars: by Sanjay Popat (London), Tom Newsom-Davis (London), Stephen Harrow (Glasgow), A summary of ASCO 2020 to include: Immuno-oncology in advanced NSCLC and SCLC and the implications of C-19 (CHECKMATE-9LA, CITYSCAPE, CASPIAN, KEYTE-604, ECOG-ACRIN EA5161, CCC19, TERAVOLT), TKIs, ADCs and Mesothelioma (ADAURA, ADJUVANT, CHRYSALIS, ECOG-ACRIN EA5162, T-DXd, DESTINY-Lung01 HER2 Mutated NSCLC, PrE0505, RAMES) Radiotherapy (LS-SCLC, SINDAS, Atezolizumab + SABR in NSCLC, PIT-1, Neoadjuvant chemorad + pembrolizumab followed by consolidation pembrolizumab in stage III NSCLC)

Attached Files